On 13th and 14th of December the Institut de Recerca de l Hospital de Sant Pau hosted the first Meeting of the ERA-NET NEURON TREAT-SYNGP project (Synaptic Dysfunction in Intellectual Disability Caused by SYNGAP1. Translational Research to Develop Human Models and Advance Pharmacological Treatments*).
The project is an European scientific consortium lead by Dr. Àlex Bayés, IP of the Molecular Physiology of the Synapse group of the IR Sant Pau. The main goal of the project is to make iPSCs harbouring SYNGAP1 mutations causing intellectual disability and to use them to identify new potential treatments.
From left to right:
Michael Peitz (Institute of Reconstructive Neurobiology, Bonn, Germany); Àlex Bayés (Institut de Recerca de l’Hospital de Sant Pau, Barcelona, Spain); Jacques Michaud (Hospital Universitaire Sainte Justine, Montreal, Canada); Daniel Choquet (Institut Interdisciplnaire de Neurosciences, Bourdeaux, France); Oliver Brüstle (Institute of Reconstructive Neurobiology, Bonn Germany)
https://www.neuron-eranet.eu/en/790.php
*Funded by the European Comission
